-
公开(公告)号:US10851081B2
公开(公告)日:2020-12-01
申请号:US16861646
申请日:2020-04-29
Applicant: Pfizer Inc.
Inventor: Gary Erik Aspnes , Scott W. Bagley , John M. Curto , Matthew S. Dowling , David Edmonds , Mark E. Flanagan , Kentaro Futatsugi , David A. Griffith , Kim Huard , Gajendra Ingle , Wenhua Jiao , Chris Limberakis , Alan M. Mathiowetz , David W. Piotrowski , Roger B. Ruggeri
IPC: C07D401/14 , C07D471/04 , A61K31/4545 , C07D487/04 , A61P3/00 , A61P15/10 , A61P17/06 , A61P9/10 , A61P19/06 , A61P25/28 , A61P25/30 , A61P43/00 , A61P1/16 , A61P25/02 , A61P3/04 , A61P19/02 , A61P3/10 , A61P13/12 , A61P25/18 , A61P1/00 , A61P15/00 , A61P25/16 , C07D405/14 , C07D413/14 , A61K31/496
Abstract: Provided herein are 6-carboxylic acids of benzimidazoles and 4-aza-, 5-aza-, 7-aza- and 4,7-diaza-benzimidazoles as GLP-1R agonists, processes to make said compounds, and methods comprising administering said compounds to a mammal in need thereof.
-
公开(公告)号:US20190382387A1
公开(公告)日:2019-12-19
申请号:US16535553
申请日:2019-08-08
Applicant: Pfizer Inc.
Inventor: Gary Erik Aspnes , Scott W. Bagley , John M. Curto , David James Edmonds , Mark E. Flanagan , Kentaro Futatsugi , David A. Griffith , Kim Huard , Yajing Lian , Chris Limberakis , Allyn T. Londregan , Alan M. Mathiowetz , David W. Piotrowski , Roger B. Ruggeri
IPC: C07D405/12 , C07D405/14 , C07C53/10 , C07D471/04 , C07C215/40 , C07C53/06 , C07D413/14
Abstract: Provided herein are 6-carboxylic acids of benzimidazoles and 4-aza-, 5-aza-, and 7-aza-benzimidazoles as GLP-1R agonists, processes to make said compounds, and methods comprising administering said compounds to a mammal in need thereof.
-
公开(公告)号:US10174007B2
公开(公告)日:2019-01-08
申请号:US15729885
申请日:2017-10-11
Applicant: Pfizer Inc.
Inventor: Matthew Dowling , Dilinie Fernando , Kentaro Futatsugi , Kim Huard , Thomas Victor Magee , Brian Raymer , Andre Shavnya , Aaron Smith , Benjamin Thuma , Andy Tsai , Meihua Tu
IPC: A61K31/403 , C07D403/14 , C07D401/04 , C07D401/14 , C07D403/04
Abstract: Provided herein are substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors, processes to make said compounds, and methods comprising administering said compounds to a mammal in need thereof.
-
公开(公告)号:US20180042926A1
公开(公告)日:2018-02-15
申请号:US15693785
申请日:2017-09-01
Applicant: Pfizer Inc.
Inventor: Kentaro Futatsugi
IPC: A61K31/506 , C07D491/08 , C07D487/02 , A61K31/5377 , C07D413/14 , A61K31/606 , C07D401/14 , A61K31/4545 , A61K45/06 , C07D487/04 , C07D401/04
CPC classification number: A61K31/506 , A61K31/4545 , A61K31/5377 , A61K31/606 , A61K45/06 , C07D401/04 , C07D401/14 , C07D413/14 , C07D487/02 , C07D487/04 , C07D491/08
Abstract: Compounds of Formula I that inhibit the activity of the diacylglycerol acyltransferase 2 (DGAT2) and their uses in the treatment of diseases linked thereto in animals are described herein.
-
公开(公告)号:US20180037575A1
公开(公告)日:2018-02-08
申请号:US15729885
申请日:2017-10-11
Applicant: Pfizer Inc.
Inventor: Matthew Dowling , Dilinie Fernando , Kentaro Futatsugi , Kim Huard , Thomas Victor Magee , Brian Raymer , Andre Shavnya , Aaron Smith , Benjamin Thuma , Andy Tsai , Meihua Tu
IPC: C07D403/14 , C07D401/14 , C07D401/04 , C07D403/04 , A61K31/403
CPC classification number: C07D403/14 , A61K31/403 , C07D401/04 , C07D401/14 , C07D403/04
Abstract: Provided herein are substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors, processes to make said compounds, and methods comprising administering said compounds to a mammal in need thereof.
-
公开(公告)号:US09809579B2
公开(公告)日:2017-11-07
申请号:US15381295
申请日:2016-12-16
Applicant: Pfizer Inc.
Inventor: Matthew Dowling , Dilinie Fernando , Kentaro Futatsugi , Kim Huard , Thomas Victor Magee , Brian Raymer , Andre Shavnya , Aaron Smith , Benjamin Thuma , Andy Tsai , Meihua Tu
IPC: C07D401/14 , C07D403/14 , C07D403/04 , C07D401/04 , A61K31/403
CPC classification number: C07D403/14 , A61K31/403 , C07D401/04 , C07D401/14 , C07D403/04
Abstract: Provided herein are substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors, processes to make said compounds, and methods comprising administering said compounds to a mammal in need thereof.
-
公开(公告)号:US20150099782A1
公开(公告)日:2015-04-09
申请号:US14506752
申请日:2014-10-06
Applicant: PFIZER INC.
Inventor: Kevin Barry Bahnck , David James Edmonds , Kentaro Futatsugi , Esther Cheng Yin Lee , Alan Martin Mathiowetz , Elnaz Menhaji-Klotz , Robert Vernon Stanton
IPC: C07D401/14
CPC classification number: C07D401/14
Abstract: Provided herein are antagonists of prostaglandin EP3 receptor, processes to make said antagonists, and methods comprising administering said antagonists to a mammal in need thereof.
Abstract translation: 本文提供前列腺素EP3受体的拮抗剂,制备所述拮抗剂的方法,以及包括向有需要的哺乳动物施用所述拮抗剂的方法。
-
-
-
-
-
-